Skip to content
healthcare.dev
Get a free key

PEMAZYRE

NDC 50881-028, pemigatinib, tablet, from Incyte Corporation.

Product NDC
50881-028
Status
Listed
Labeler
Incyte Corporation
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA213736
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50881-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PEMIGATINIB13.5 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Organic Cation Transporter 2 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
50881-028-015088100280114 TABLET in 1 BOTTLE, PLASTIC (50881-028-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9e1f2222-1d89-4e63-989c-ccebe2ab1eb4

Use it

Look up 50881-028 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50881-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50881-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.